Oxford COVID-19 vaccine is safe and protects against disease, first published results from phase 3 trials
Interim results of the Oxford COVID-19 vaccine trials find that the vaccine protects against symptomatic disease in 70% of cases—with vaccine efficacy of 62% for those given two full doses, and of 90% in those given a half ...
Dec 08, 2020
0
30